http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Sarepta (SRPT), Summit Therapeutics (SMMT) Enter Licensing Agreement for Utrophin Modulator Pipeline
-
Sarepta Therapeutics and Summit Enter Into Exclusive License and Collaboration Agreement for European Rights to Summit’s Utrophin Modulator Pipeline for the Treatment of Duchenne Muscular Dystrophy
-
Pre-Open Stock Movers 09/28: (SEED) (AVXL) (ATHX) Higher; (GALT) (TPX) (SONC) Lower (more...)
-
Top 10 News for 9/19 - 9/23: Twitter on the Auction Block; Allergan Bolsters NASH Effort; Microsoft Returns Value
-
Stocks with call strike movement; SRPT TWTR
-
Pre-Open Stock Movers 06/20: (LPTN) (FATE) (CERS) Higher (more...)
-
Top 10 News for 5/23 - 5/27: Computer Sciences to Acquire Key Enterprise Asset; Bayer Makes Run at Monsanto; Twitter has 'Character' Change
-
FDA Panel Starts Getting Cautious on Sarepta's (SRPT) Eteplirsen
-
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Sarepta Therapeutics, Inc. and Advises Investors with Losses in Excess of $100,000 to Contact the Firm
-
Pre-Open Stock Movers 01/21: (ZFGN) (XLNX) (FEYE) Higher; (OGXI) (ALKS) (SLM) Lower (more...)
-
UPDATE: TheStreetSweeper Says 'We're Short' on Sarepta Therapeutics (SRPT)
-
Pre-Open Stock Movers 04/01: (VLTC) (DYAX) (SHLD) Higher; (CTSO) (UTIW) (MAC) Lower (more...)
-
Scottish Government Confirms First Case of Ebola - CNBC
-
Notable Analyst Rating Changes 10/28: (TWTR) (DRYS) (TRN) Upgraded; (SRPT) (BG) (NBR) Downgraded
-
Market Wrap: Valeant Lifts Allergan Bid; Twitter's Ho-Hum Q3 Report; Tesla Slumps on Sales Speculation
-
Prosensa Holding (RNA) CEO to Appear on CNBC's Fast Money
-
Notable Analyst Rating Changes 01/06: (SCTY) (BSX) (AIG) Upgraded; (TWTR) (AAPL) (SRPT) Downgraded
-
Notable Analyst Rating Changes 11/12: (XTEX) (LF) (BCRX) Upgraded; (SRPT) (GOGO) (CLH) Downgraded
-
Streetinsider.com's Hot Lunchtime Reads 10/09: (SRPT) (JCP) (AAPL) (HPQ)
-
Sarepta Therapeutics (SRPT) Falls on New Short Report
-
Sarepta Therapeutics (SRPT) Issues Statement on Error
-
Sarepta Therapeutics (SRPT) Sees Wild Late-Day Action
-
Stocks Crossing 50-Day SMA 01/30: (EMC) (SRPT) (SWKS) Above; (ANR) (TRQ) (JDSU) Below
-
Another Short Seller Twitter Hoax Hits a High Flying Stock (SRPT) (ADNC)
-
Sarepta Therapeutics (SRPT) Moves Higher as Ex-FDA Official Sees Accelerated Approval
-
Sarepta Therapeutics (SRPT) Riding High On Successful Drug

